Comparison Overview

Cutting Edge Medical

VS

Beckman Coulter Diagnostics

Cutting Edge Medical

3515 Sycamore School Rd, Fort Worth, Texas, 76133, US
Last Update: 2025-05-05 (UTC)
Between 800 and 900

Strong

Cutting Edge Medical is a privately held medical supplier and distributor corporation with expertise in marketing and distribution of surgical devices and implants. . The company has received many national sales awards in the orthopedic industry and Patti Corder, the founding owner, has over 16 years in the orthopedics including sales, implants, implant product development, consulting, and nursing.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 5
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Beckman Coulter Diagnostics

250 S Kraemer Blvd, Brea, California, 92821, US
Last Update: 2025-05-06 (UTC)

Strong

A global leader in advanced diagnostics, Beckman Coulter has challenged convention to elevate the diagnostic laboratoryโ€™s role in improving patient health for more than 80 years. Our mission is to Relentlessly Reimagine Healthcare, One Diagnosis at a Time โ€“ and we do this by applying the power of science, technology and the passion and creativity of our teams. Our diagnostic solutions are used in complex clinical testing, and are found in hospitals, reference laboratories and physician office settings around the globe. We exist to deliver smarter, faster diagnostic solutions that move the needle forward from whatโ€™s now to whatโ€™s next. We do this by accelerating care with an extensive clinical menu, scalable lab automation technologies, insightful clinical informatics, and optimize lab performance services. Headquartered in Brea, Calif., Beckman Coulter Diagnostics has more than 11,000 global team members. Beckman Coulter is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrowโ€™s science and technology to improve human health.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 11,084
Subsidiaries: 67
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/cutting-edge-medical.jpeg
Cutting Edge Medical
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/beckman-coulter.jpeg
Beckman Coulter Diagnostics
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
Cutting Edge Medical
100%
Compliance Rate
0/4 Standards Verified
Beckman Coulter Diagnostics
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Cutting Edge Medical in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Beckman Coulter Diagnostics in 2025.

Incident History โ€” Cutting Edge Medical (X = Date, Y = Severity)

Cutting Edge Medical cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” Beckman Coulter Diagnostics (X = Date, Y = Severity)

Beckman Coulter Diagnostics cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/cutting-edge-medical.jpeg
Cutting Edge Medical
Incidents

No Incident

https://images.rankiteo.com/companyimages/beckman-coulter.jpeg
Beckman Coulter Diagnostics
Incidents

No Incident

FAQ

Both Cutting Edge Medical company and Beckman Coulter Diagnostics company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, Beckman Coulter Diagnostics company has disclosed a higher number of cyber incidents compared to Cutting Edge Medical company.

In the current year, Beckman Coulter Diagnostics company and Cutting Edge Medical company have not reported any cyber incidents.

Neither Beckman Coulter Diagnostics company nor Cutting Edge Medical company has reported experiencing a ransomware attack publicly.

Neither Beckman Coulter Diagnostics company nor Cutting Edge Medical company has reported experiencing a data breach publicly.

Neither Beckman Coulter Diagnostics company nor Cutting Edge Medical company has reported experiencing targeted cyberattacks publicly.

Neither Cutting Edge Medical company nor Beckman Coulter Diagnostics company has reported experiencing or disclosing vulnerabilities publicly.

Beckman Coulter Diagnostics company has more subsidiaries worldwide compared to Cutting Edge Medical company.

Beckman Coulter Diagnostics company employs more people globally than Cutting Edge Medical company, reflecting its scale as a Medical Equipment Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X